Rocket Lab Shares Gain Ahead of Crucial Earnings Report

Rocket Lab USA US7731221062

Shares of Rocket Lab USA advanced on Tuesday, closing 3.6% higher at $69.89. During the session, the stock reached an intraday peak of $70.99. Trading activity, however, was notably subdued, with volume of approximately 11.9 million shares coming in 49% below the average.

All eyes are now on February 26, when the company is scheduled to release its financial results for the fourth quarter and the full fiscal year 2025.

The recent uptick follows a period of significant pressure. After hitting a 52-week high of $99.58 in mid-January, the equity experienced a sharp correction, losing over 5% at one point during the recent market pullback.

Market expectations are set for the upcoming report. Analysts project Q4 revenue to be around $177.9 million. For the full 2025 fiscal year, expert consensus points to total revenue of approximately $600 million, which would represent substantial growth compared to the prior year.

Defense Contracts and Hypersonic Missions

The company's defense segment continues to be a focal point. On February 12, Rocket Lab announced its next launch, the "Cassowary Vex" mission, scheduled for no earlier than late February from Virginia. This flight is a hypersonic test for the U.S. Department of Defense's Defense Innovation Unit.

The mission will deploy the DART AE, a scramjet aircraft developed by the Australian firm Hypersonix. This marks Rocket Lab's fourth hypersonic test mission within a six-month span, underscoring its expanding role in the defense sector. Furthermore, in December 2025, the company secured its largest contract to date: an $816 million agreement with the Space Development Agency for missile defense satellites.

Divergent Views from Wall Street

Analyst sentiment on the stock is mixed. The consensus rating currently stands at "Moderate Buy," with an average price target of $72.92. However, individual firm assessments vary widely:

• Goldman Sachs: Maintains a "Neutral" stance but raised its price target from $47 to $69.
• Bank of America: Issues a "Buy" rating with a $120 price objective.
• Morgan Stanley: Upgraded the stock to "Overweight" with a $105 target.

Institutional ownership remains high at about 71.8% of shares outstanding. Significant recent activity includes The Vanguard Group, which increased its stake by 13.4% in Q4 to roughly 47.4 million shares. Baillie Gifford & Co. boosted its position by a notable 176.1% in the third quarter to about 12.1 million shares.

Key Levels and Upcoming Catalyst

With a market capitalization near $37.3 billion, Rocket Lab ranks among the larger pure-play space companies. Technically, the stock is currently trading below its 50-day moving average of $76.19 but remains above its 200-day moving average of $59.70.

The quarterly report on February 26 is anticipated to provide critical clarity on the company's ability to meet its growth trajectory. Investors will scrutinize performance in the government sector and the pipeline for future large-scale contracts.